<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FORM THE FINANCIAL STATEMENTS FOR REPLIGEN CORPORATION AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000730272 <NAME> REPLIGEN CORPORATION <MULTIPLIER> 1 <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> MAR-31-1995 <PERIOD-START> APR-01-1994 <PERIOD-END> MAR-31-1995 <CASH> 13,821,387 <SECURITIES> 1,480,712 <RECEIVABLES> 1,986,902 <ALLOWANCES> (300,000) <INVENTORY> 1,213,379 <CURRENT-ASSETS> 24,823,938 <PP&E> 20,296,538 <DEPRECIATION> (15,312,326) <TOTAL-ASSETS> 31,329,953 <CURRENT-LIABILITIES> 15,753,569 <BONDS> 0 <COMMON> 153,570 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 15,422,814 <TOTAL-LIABILITY-AND-EQUITY> 31,329,953 <SALES> 3,884,642 <TOTAL-REVENUES> 16,942,315 <CGS> 1,535,026 <TOTAL-COSTS> 32,546,919 <OTHER-EXPENSES> 16,345,713 <LOSS-PROVISION> 440,031 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (31,950,317) <INCOME-TAX> 0 <INCOME-CONTINUING> (31,950,317) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (31,950,317) <EPS-PRIMARY> (2.08) <EPS-DILUTED> (2.08)